Alto Neuroscience ANRO 深 沪
等待开盘 08-25 09:30:00 美东时间
36.76
+2.480
+7.23%
华盛通- 最 高36.99
- 今 开34.08
- 成交量 68.92万股
- 最 低 33.5201
- 昨 收 34.28
- 总市值 14.43亿
- 52周最高 36.99
- 市盈率 静 --
- 换手率 1.76%
- 52周最低 3.41
- 委 比 20.00%
- 总股本 3924.21万
- 历史最高 36.99
- 量 比 1.65
- 振 幅 10.12%
- 历史最低 1.60
- 每 手 1
- 风险率 7.80%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅455.56%！Cardiol Therapeutics获Canaccord Genuity上调目标价至10美元，维持"买入"评级
今日重点评级关注：Canaccord Genuity：维持Cardiol Therapeutics"买入"评级，目标价从8美元升至10美元；B. Riley证券：维持Macrogenics"买入"评级，目标价从9美元升至11美元
08-18 11:39
美股大行评级 | 潜在涨幅544.53%！Scynexis获古根海姆升目标价至33美元，维持"买入"评级
今日重点评级关注：古根海姆：维持Scynexis"买入"评级，目标价从24美元升至33美元；韦德布什：维持Kura Oncology"跑赢大市"评级，目标价从36美元升至38美元
08-14 11:51
BTIG Maintains Buy on Alto Neuroscience, Raises Price Target to $37
BTIG analyst Thomas Shrader maintains Alto Neuroscience (NYSE:ANRO) with a Buy and raises the price target from $28 to $37.
08-13 18:12
Alto Neuroscience Q2 EPS $(0.65) Beats $(0.73) Estimate
Alto Neuroscience (NYSE:ANRO) reported quarterly losses of $(0.65) per share which beat the analyst consensus estimate of $(0.73) by 10.96 percent. This is unchanged from the same period last year.
08-13 04:19
Alto Neuroscience宣布1亿美元普通股注册直接发行定价
临床阶段生物制药公司Alto Neuroscience近日宣布，已确定其承销注册直接发行的定价。此次发行共计3，776，436股普通股，每股价格为26.4...
07-13 20:40
Alto Neuroscience Prices ~$100M Offering Of 3.776M Common Shares At $26.48/Share
Alto Neuroscience, Inc. ("Alto") (NYSE:ANRO), a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging neurobiology to develop personalized and highly effective treatment options, announced today the pricing of an underwritten registered direct offering of 3,776...
07-13 19:48
Alto Neuroscience Intends To Accelerate And Expand Clinical Development Of ALTO-207, Including An Additional Planned Phase 3 Trial As Monotherapy For Treatment-Resistant Depression
On July 13, 2026, Alto Neuroscience, Inc. (the "Company") announced that, based upon preliminary estimates and information available to the Company, it estimates that its cash, cash equivalents and restricted cash were approximately $244.2 million as of June 30, 2026. This amount has not been audite...
07-13 19:46
Tesla, AMD, and SpaceX headline Cathie Wood's biggest H1 portfolio bets
H1 2026 performance Cathie Wood's ARK Invest funds delivered mixed performance during the first half of 2026, with two ETFs outperforming the broader U.S. market. The ARK Space & Defense Innovation ET...
07-07 00:15
美股牛股 | NUVL飙升39%，获葛兰素史克高额溢价收购；Velo3D大涨近20%
NUVL飙升39%，获葛兰素史克高额溢价收购；Velo3D大涨近20%，进军燃气轮机增材制造领域；职业教育涨逾18%，收购整合完成后大幅上调营收预期>>
06-10 18:45
